Cancer Network | Colorectal Cancer
111 FOLLOWERS
Updates for oncologists treating colon and rectal cancer, including guidelines, therapies, and screening by colonoscopy, FIT, stool DNA, and fecal occult blood tests.
Cancer Network | Colorectal Cancer
2h ago
Patients who are African American appeared to have worse clinical stages of colon and rectal cancer during surgery in 2020 ..read more
Cancer Network | Colorectal Cancer
2h ago
ME-344 and bevacizumab can now have an additional 20 patients enrolled on the phase 1b trial for relapsed metastatic colorectal cancer ..read more
Cancer Network | Colorectal Cancer
1w ago
The PREEMPT trial analyzed samples from 27,010 average-risk adults to determine the specificity of detecting colorectal cancer ..read more
Cancer Network | Colorectal Cancer
1w ago
Data from the phase 1/2 KRYSTAL-1 trial may support adagrasib plus cetuximab as a new standard in previously treated metastatic KRAS G12C–mutated CRC ..read more
Cancer Network | Colorectal Cancer
3w ago
Long-term circulating tumor DNA responses appear to align with progression-free survival trends in a phase 2/3 trial of the GRANITE vaccine in those with microsatellite-stable colorectal cancer ..read more
Cancer Network | Colorectal Cancer
3w ago
Gut microbiome signatures may lead the way for more accurate treatments and diagnoses for patients with colorectal cancer ..read more
Cancer Network | Colorectal Cancer
3w ago
If possible, targeting the BER pathway for drug sensitivities may increase therapeutic options for managing solid cancers, wrote Channing Paller, MD ..read more
Cancer Network | Colorectal Cancer
1M ago
Results from part 3 of the phase 2a CORIST trial found that combining SCO-101 with chemotherapy improved the progression-free survival and clinical benefit rate in patients with metastatic colorectal cancer ..read more
Cancer Network | Colorectal Cancer
1M ago
Investigators of the AMPLIFY-201 trial hypothesized that ELI-002 2P may induce the expansion of functional tumor-directed KRAS-mutated specific T cells following tumor resection ..read more
Cancer Network | Colorectal Cancer
1M ago
Panitumumab plus modified FOLFOX6 appears to increase survival among patients with metastatic colorectal cancer and circulating tumor DNA that has no gene alterations in the PARADIGM trial ..read more